US
US PTSD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Population, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $760.0 Mn.
Canada at 5.8% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$312.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $731.5 Mn | — | — |
| 2025 (base) | $760.0 Mn | +$28.5 Mn | — |
| 2026 (forecast) | $789.6 Mn | +$29.6 Mn | +3.9% |
| 2027 (forecast) | $820.4 Mn | +$30.8 Mn | +8% |
| 2028 (forecast) | $852.4 Mn | +$32.0 Mn | +12.2% |
| 2029 (forecast) | $885.7 Mn | +$33.2 Mn | +16.5% |
| 2030 (forecast) | $920.2 Mn | +$34.5 Mn | +21.1% |
| 2031 (forecast) | $956.1 Mn | +$35.9 Mn | +25.8% |
| 2032 (forecast) | $993.4 Mn | +$37.3 Mn | +30.7% |
| 2033 (forecast) | $1.03 Bn | +$38.7 Mn | +35.8% |
| 2034 (forecast) | $1.07 Bn | +$40.3 Mn | +41.1% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$760.0 Mn
China
$132.5 Mn
Japan
$121.1 Mn
Canada
$118.1 Mn
Germany
$67.3 Mn
UK
$42.7 Mn
France
$43.2 Mn
Brazil
$43.9 Mn
Italy
$34.7 Mn
Ecuador
$33.1 Mn
India
$31.7 Mn
Spain
$29.0 Mn
Saudi Arabia
$29.5 Mn
Mexico
$27.2 Mn
Australia
$22.3 Mn
Russia
$19.0 Mn
New Zealand
$16.5 Mn
South Africa
$11.7 Mn
UAE
$9.5 Mn
Egypt
$4.4 Mn
Philippines
$4.0 Mn
Malaysia
$3.1 Mn
Hong Kong
$2.5 Mn
Singapore
$1.9 Mn
Thailand
$1.9 Mn
Kenya
$1.2 Mn
PTSD treatment helps people recover from trauma using therapies, medicines and new approaches such as MDMA-assisted therapy.
Key segments of the PTSD Treatment market include treatment (Psychotherapy, SSRIs and SNRIs and Psychedelic-Assisted Therapy) and population (Veterans and Military and Civilians).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the PTSD Treatment market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the PTSD Treatment market.
The PTSD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for PTSD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in US.
What doctors and scientists are doing in PTSD Treatment right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 2 shared keywords
US · 1 shared keyword
US · 1 shared keyword
US
US
US
OTC & Nutraceuticals · US
Digital Health · US
Digital Health · US
OTC & Nutraceuticals · US
Healthcare Services · US
Healthcare Services · US